Phasei Open Label News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phasei Open Label. Real-time updates on events, politics, business and more.

Harbour BioMed Reports the Latest Progress of Next-Generation Fully Human Heavy-chain Antibody HBM4003 with Unique Treg Depletion Mechanism

June 1, 2022

/PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization...

United States United Kingdom Hong Kong Humphrey Gardner American Society Of Clinical Oncology Harbour Biomed The Company

Source: prnewswire.com

Harbour BioMed to Present the Latest Progress of Next-Generation Anti-CTLA-4 Antibody HBM4003 at 2022 ASCO Annual Meeting

May 10, 2022

/PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization...

United States United Kingdom Humphrey Gardner Prnewswire Harbour Biomed The Company American Society Of Clinical Oncology Clinical Oncology

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Phasei Open Label News Today

Harbour BioMed Reports the Latest Progress of Next-Generation Fully Human Heavy-chain Antibody HBM4003 with Unique Treg Depletion Mechanism

Harbour BioMed to Present the Latest Progress of Next-Generation Anti-CTLA-4 Antibody HBM4003 at 2022 ASCO Annual Meeting

Explore More Categories